BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 31288390)

  • 1. VDAC1 and the TSPO: Expression, Interactions, and Associated Functions in Health and Disease States.
    Shoshan-Barmatz V; Pittala S; Mizrachi D
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control.
    Gatliff J; East D; Crosby J; Abeti R; Harvey R; Craigen W; Parker P; Campanella M
    Autophagy; 2014; 10(12):2279-96. PubMed ID: 25470454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone synthesis in mitochondria.
    Miller WL
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):62-73. PubMed ID: 23628605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
    Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
    Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDAC1 functions in Ca
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
    Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
    Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
    Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
    Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
    Ben-Hail D; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
    Shoshan-Barmatz V; Mizrachi D; Keinan N
    Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial VDAC, the Na
    Shoshan-Barmatz V; De S
    Adv Exp Med Biol; 2017; 981():323-347. PubMed ID: 29594867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for TSPO in mitochondrial Ca
    Gatliff J; East DA; Singh A; Alvarez MS; Frison M; Matic I; Ferraina C; Sampson N; Turkheimer F; Campanella M
    Cell Death Dis; 2017 Jun; 8(6):e2896. PubMed ID: 28640253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSPO: An Evolutionarily Conserved Protein with Elusive Functions.
    Bonsack F; Sukumari-Ramesh S
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29875327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.
    Veenman L; Shandalov Y; Gavish M
    J Bioenerg Biomembr; 2008 Jun; 40(3):199-205. PubMed ID: 18670869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response.
    Veenman L; Papadopoulos V; Gavish M
    Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator protein (TSPO) role in aging and Alzheimer's disease.
    Repalli J
    Curr Aging Sci; 2014; 7(3):168-75. PubMed ID: 25495567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TSPO/VDAC1 Upregulation and Matrix Metalloproteinase-2 Localization in the Dysfunctional Myocardium of Hyperglycaemic Rats.
    Gliozzi M; Scarano F; Musolino V; Carresi C; Scicchitano M; Ruga S; Zito MC; Nucera S; Bosco F; Maiuolo J; Macrì R; Guarnieri L; Mollace R; Coppoletta AR; Nicita C; Tavernese A; Palma E; Muscoli C; Mollace V
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.